NEW YORK (GenomeWeb News) – Insight Genetics said Tuesday that it has been chosen by the National Cancer Institute to participate in the institute's Clinical Assay Development Program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.